Back
MoonLake Immunotherapeutics Stock Price Chart
Sponsored
MLTX
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
30
MLTX
MoonLake Immunotherapeutics
Last Price:
$52.27
Seasonality Move:
32.39%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.03 | Sell |
20-day SMA: | 53.42 | Sell |
50-day SMA: | 50.78 | Buy |
200-day SMA: | 46.72 | Buy |
8-day EMA: | 52.87 | Sell |
20-day EMA: | 52.74 | Sell |
50-day EMA: | 51.49 | Buy |
200-day EMA: | 48.38 | Buy |
MoonLake Immunotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 49.27 | Sell |
Chaikin Money Flow: | 1487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.72 - 54.62) | Sell |
Bollinger Bands (100): | (46.36 - 52.96) | Buy |
MoonLake Immunotherapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 52.17 while MLTX 8-day simple moving average is 53.03, which is a Sell signal.
-
The stock price of MLTX is 52.17 while MoonLake Immunotherapeutics 20-day SMA is 53.42, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day simple moving average is 50.78 while MLTX share price is 52.17, making it a Buy technically.
-
MLTX stock price is 52.17 and MoonLake Immunotherapeutics 200-day simple moving average is 46.72, creating a Buy signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
30
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $52.17. The Score for MLTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
3.3B
Price in USD:
52.17
Share Volume:
192.8K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
37.55
Sell
30
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 52.17 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 52.17 while MLTX 8-day exponential moving average is 52.87, which is a Sell signal.
-
The stock price of MLTX is 52.17 while MoonLake Immunotherapeutics 20-day EMA is 52.74, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 51.49 while MLTX share price is 52.17, making it a Buy technically.
-
MLTX stock price is 52.17 and MoonLake Immunotherapeutics 200-day simple moving average is 48.38, creating a Buy signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.77 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is 0.45, suggesting MoonLake Immunotherapeutics is a Buy
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 49.27, which suggest MoonLake Immunotherapeutics is oversold
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (50.72 - 54.62), which suggest MoonLake Immunotherapeutics is a Buy
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (46.36 - 52.96), which suggest MoonLake Immunotherapeutics is a Buy
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.